• FAISL, FAK Proteolysis, and TNBC Metastasis

  2026-08-17

  The 2024 Advanced Science study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis. Its findings connect lncRNA-dependent control of FAK protein turnover with triple-negative breast cancer adhesion, survival, progression, and metastasis, while providing a rationale for FAISL-targeted RNA delivery.

• Apigenin Workflows for Oncology and Neuroprotection

  2026-08-17

  Apigenin supports parallel oncology and neuroprotection workflows by combining HDAC-linked apoptosis studies with ROS, DNA-damage, mitochondrial, and inflammation readouts. This practical guide covers dosing, assay design, cross-model interpretation, and troubleshooting for more reproducible preclinical experiments.

• Spermine: Designing Causal Ion Channel Assays

  2026-08-16

  Spermine is an endogenous polyamine whose voltage-dependent control of IRK1 channels makes it valuable for disciplined ion channel regulation studies. This evidence-calibrated guide connects channel assays with emerging herpesvirus nuclear egress research while separating established mechanisms from testable hypotheses.

• Rottlerin: A PKC Probe for Entry Biology

  2026-08-15

  Rottlerin is a PKC inhibitor with applications extending from apoptosis and cell proliferation to mechanistic studies of pathogen entry. This article develops an assay-centered framework connecting Rottlerin pharmacology with Spiroplasma eriocheiris uptake in Drosophila S2 cells while emphasizing controls, interpretation, and cross-domain limitations.

• Losmapimod: From p38 Binding to Assay Design

  2026-08-14

  Losmapimod and GW856553X offer a precise way to interrogate p38α/β signaling. This article translates structural evidence on kinase–phosphatase coupling into better assay controls for inflammation, vascular function, hypertension, and COPD research.

• Calpain Inhibitor II, ALLM: A Protease Assay Framework

  2026-08-14

  Calpain Inhibitor II, ALLM is a cell-permeable cysteine-protease inhibitor with value beyond simple apoptosis induction. This guide explains how to interpret its target profile, connect calpain-2-dependent FAK proteolysis to assay design, and avoid overclaiming selectivity in cancer models.

• Doxorubicin Hydrochloride Research Workflows

  2026-08-13

  Doxorubicin hydrochloride supports both cancer-cell mechanism studies and carefully controlled cardiotoxicity models, making it more than a simple viability reagent. This workflow shows how to connect dose response, apoptosis, metabolic stress, and cardiac safety readouts while avoiding common handling and interpretation errors.

• CCL7+ Macrophages and CRC Immunotherapy Resistance

  2026-08-13

  The reference study identifies CCL7+ tumor-associated macrophages as a mechanistic driver of immune checkpoint inhibitor resistance in colorectal cancer. Its findings connect macrophage metabolism, CXCL10-dependent CD8+ T-cell recruitment, and anti-PD-L1 response, providing a rationale for testing macrophage-centered combination strategies.

• Pancreatic Ductal Organoids: A Small-Molecule Protocol

  2026-08-12

  Liao and colleagues developed a small-molecule culture strategy that improves the initiation and long-term expansion of pancreatic ductal organoids while retaining ductal and acinar populations. The approach provides a more efficient platform for pancreatic disease modeling, cellular plasticity studies, and future high-throughput drug screening.

• Birinapant (TL32711) for Cancer Apoptosis Workflows

  2026-08-12

  Birinapant (TL32711) converts IAP biology into a practical sensitization strategy for apoptosis, TRAIL, TNF, and chemoradiotherapy studies. This workflow connects mechanistic readouts with MDM1–p53 biomarker experiments to help researchers distinguish pathway engagement from nonspecific cytotoxicity.

• DiI (DiIC18(3)) Plasma Membrane Probe

  2026-08-11

  DiI (DiIC18(3)) is a lipophilic orange fluorescent probe for high-contrast plasma membrane labeling in live or fixed cells and tissues. It is suitable for neuronal tracing, migration, adhesion, fusion, and lipoprotein workflows, but not for water-soluble staining or selective labeling of non-membrane organelles.

• Protein A/G Magnetic Co-IP/IP Kit for BATF2–ATF3

  2026-08-11

  The Protein A/G Magnetic Co-IP/IP Kit enables a practical strategy for testing BATF2–ATF3 regulation, ubiquitination, and protein-complex behavior in intervertebral disc degeneration research.

• Recombinant Human IL-15 for Immune Assays

  2026-08-10

  Recombinant Human IL-15 provides a defined, tag-free cytokine input for T cell activation, Natural killer cell proliferation, and controlled immune response modulation. This guide connects practical IL-15 assay design with emerging neuroimmune questions raised by early-life adversity research, while clearly separating established evidence from testable extensions.

• Pifithrin-α: A Translational p53 Playbook

  2026-08-09

  Pifithrin-α (PFTα) gives translational researchers a controlled way to interrogate p53-driven apoptosis, growth arrest, radiation responses, and ferroptosis. This thought-leadership guide connects mechanistic evidence from neurotoxicity research with practical experimental strategy, formulation guidance, and a realistic view of translational potential.

• Abiraterone acetate in Prostate Cancer Assays

  2026-08-08

  This scenario-driven guide explains how Abiraterone acetate, SKU A8202, can be integrated into prostate cancer viability, proliferation, and androgen-pathway assays. It connects formulation data with patient-derived spheroid evidence to help researchers distinguish mechanistic response from nonspecific cytotoxicity and improve experimental consistency.

16420 records 1/1095 page Next 12345 下5页 Last page